This study investigated the effects of Galileo Therapy using the Galileo Mano Med on reduction of upper-limb dysfunction in breast cancer patients during 6 weeks of acute radio therapy. The patients received over a period of 6 weeks three times per week 20 minutes Galileo Therapy. The Galileo Mano Therapy consisted of 5 exercises targeting three different aspects (relaxation: 8-12Hz, active coordination: 16-20Hz, improvement muscle function: 22-30Hz). In addition, the patient received also 20 min. of ergometer training and 20 minutes of balance training per session.
As a result, the patients showed a significantly improved upper-limb function (+9%), flexibility (+23%) bat also general fitness and a reduced mental fatigue (-18%). These results show how effective Galileo Therapy can be used very effectively also in acute (breast)cancer therapy. The study is in line with results of the university of Ulm showing a significant reduction of poly-neuropathy (pain) during acute chemo therapy (#GRPF153).
#GRFS152 #GalileoResearchFacts #GalileoTherapy #VibrationTraining #MechanoStimulation #GalilleoMano #BreastCancer #RadioTherapy #DumbbellTherapy #Oncology
The verdict of our customers: Excellent
4.7 out of 5 stars based on 868 reviews
Since 1996 we support our Galileo® customers worldwide.
Development and production exclusively in Germany.
10-year service guarantee &
5 year warranty for private customers in Germany
Unlimited user support for all Galileo customers.
Efficacy proven by over 500 scientific publications.
Winter vacation
Dear customers,
Our colleagues have been working for you and your wishes all year – now we’re giving them a well-deserved break. From 24.12.2025 to 6.1.2026, we’re swapping phones for Christmas movies and to-do lists for plates of cookies.
However, our contact form remains as vigilant as a Christmas angel – feel free to write to us and we will get back to you on January 7, 2026, when we are back, refreshed and full of energy!
Merry Christmas and a magical new year
Your Galileo Team
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information